Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension: a Multicenter, Randomized, Controlled Phase II/III Clinical Trial (PARADISE HTN-III)

NCT06283758 is registered in ClinicalTrials.gov with Suzhou Municipal Hospital as lead sponsor.

NCT NCT06283758
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06283758 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension: a Multicenter, Randomized, Controlled Phase II/III Clinical Trial (PARADISE HTN-III)
Lead sponsor
Suzhou Municipal Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
March 1, 2024
Completion date
October 31, 2026
Enrollment
30 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure, cardiovascular diseases, hypertension